REGISTERED
on 03 Sep 2024
Last Applicant/ Owned by
2201 SE 11TH AVE
PORTLAND
OR
97214
Serial Number
97748064 filed on 10th Jan 2023
Registration Number
7496979 registered on 03rd Sep 2024
Correspondent Address
Catherine Parrish Lake
Catherine Parrish Lake DORSEY & WHITNEY LLP
111 S. MAIN STREET, SUITE 2100
SALT LAKE CITY, UT 84111-2176
UNITED STATES
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
VISIONGIFT
Scientific research and development in the field of eye banking, ocular tissue, ocular transplants and ophthalmic diseases; Medical and scientific laboratory services Collection of human tissue; Tissue bank services; Eye and tissue bank services; Screening, recovery, preservation, processing, and distribution of human tissue grafts to hospitals and patients; Serological testing services for medic Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Collection of human tissue; Tissue bank services; Eye and tissue bank services; Screening, recovery, preservation, processing, and distribution of human tissue grafts to hospitals and patients; Serological testing services for medical, epidemiological purposes; Providing information in the field of tissue donation; Charitable services, namely, providing tissue bank services featuring ocular tissue for those in need; isolation, collection, preparation in the nature of medical processing and banking of ocular tissue
First Use Date in General
31st Dec 2022
First Use Date in Commerce
31st Dec 2022
Class [042]
Computer & Software Services & Scientific Services
Scientific research and development in the field of eye banking, ocular tissue, ocular transplants and ophthalmic diseases; Medical and scientific laboratory services
First Use Date in General
31st Dec 2022
First Use Date in Commerce
31st Dec 2022
Class [041]
Education and Entertainment Services
Education services, namely, training doctors and tissue banks with regard to ocular transplants and surgical procedures
First Use Date in General
31st Dec 2022
First Use Date in Commerce
31st Dec 2022
Class [036]
Insurance & Financial Services
Charitable fundraising to support eye and eye disease research, ocular transplants, ocular donations, public education on ocular transplants, training of ophthalmologists, and vision screenings
First Use Date in General
31st Dec 2022
First Use Date in Commerce
31st Dec 2022
Class [005]
Pharmaceutical Products
Biological tissue, namely, sterile cornea allograft tissue intended for subsequent implantation; Biological tissue, namely, sclera, pericardium, and sterile cornea allograft tissue intended for subsequent implantation; Surgical implants comprised of living tissues; Biological tissue grafts; Biological eye tissue intended for subsequent implantation; Corneas being biological eye tissue intended for subsequent implantation; Biological eye tissue, corneas, musculoskeletal tissue, and skin intended for subsequent implantation; Biological eye tissue grafts; Pharmaceutical preparations for ocular or intraocular surgery
First Use Date in General
31st Dec 2022
First Use Date in Commerce
31st Dec 2022
Class [001]
Chemical Products
Biological tissue, namely, sclera, pericardium, and sterile cornea allograft tissue for use in scientific and medical research
First Use Date in General
31st Dec 2022
First Use Date in Commerce
31st Dec 2022
Mark Details
Serial Number
No 97748064
Mark Type
No Service Mark
Attorney Docket Number
No T308053.US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 03rd Sep 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 03rd Sep 2024 | REGISTERED-PRINCIPAL REGISTER |
| 06th Apr 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 05th Apr 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 06th Mar 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 05th Mar 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 13th Feb 2024 | USE AMENDMENT FILED |
| 13th Feb 2024 | TEAS STATEMENT OF USE RECEIVED |
| 16th Jan 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 21st Nov 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |